Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

VITEK 2 AST Gram Negative Cefotaxime (<=0.25 - >=64 ug/mL)

K-Number: K161437 · 2017-02-16

Decision Date2017-02-16
Product CodeLON
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

VITEK 2 AST Gram Negative Cefotaxime (<=0.25 - >=64 ug/mL) is a medical device manufactured by bioMerieux, Inc.. It received FDA 510(k) clearance on 2017-02-16 under approval number K161437. The device is classified under product code LON. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the VITEK 2 AST Gram Negative Cefotaxime (<=0.25 - >=64 ug/mL)?

VITEK 2 AST Gram Negative Cefotaxime (<=0.25 - >=64 ug/mL) is a medical device that received FDA 510(k) clearance on 2017-02-16. It is manufactured by bioMerieux, Inc.. The 510(k) number is K161437.

When was VITEK 2 AST Gram Negative Cefotaxime (<=0.25 - >=64 ug/mL) approved by the FDA?

VITEK 2 AST Gram Negative Cefotaxime (<=0.25 - >=64 ug/mL) received FDA 510(k) clearance on 2017-02-16, under approval number K161437.

What company makes VITEK 2 AST Gram Negative Cefotaxime (<=0.25 - >=64 ug/mL)?

VITEK 2 AST Gram Negative Cefotaxime (<=0.25 - >=64 ug/mL) is manufactured by bioMerieux, Inc..

What is the FDA product code for VITEK 2 AST Gram Negative Cefotaxime (<=0.25 - >=64 ug/mL)?

The FDA product code for VITEK 2 AST Gram Negative Cefotaxime (<=0.25 - >=64 ug/mL) is LON.

Other Devices by bioMerieux, Inc.

View all 66 devices →

Related Devices (Code: LON)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.